{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:36:09Z","timestamp":1776926169668,"version":"3.51.2"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Throughout the COVID-19 pandemic, there was variability in outcomes and in the clinical and demographic characteristics of patients with severe disease. We aimed to compare clinical and demographic variables at hospital admission among patients with severe COVID-19 at two high-specialty centers in Mexico during the pandemic waves, accounting for relevant virus variants and patients' vaccination status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, descriptive study included medical records of 1,425 patients hospitalized with COVID-19 (March 2020\u2013November 2022) at the National Institute of Respiratory Diseases (INER, Mexico City, Mexico) and the Regional High Specialty Hospital of the Yucat\u00e1n Peninsula\u2013IMSS Bienestar (Merida, Yucat\u00e1n, Mexico). The comparison was performed between the 1st wave, the 2nd and 3rd waves, and the 4th to 6th waves in Mexico, among the pre-dominant SARS-CoV-2 variants (Delta and Omicron), and vaccination status during the Omicron stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At the 1st wave, patients were pre-dominantly male and younger; whereas in the 4th to 6th waves, a high frequency of subjects with heart disease was observed. The longest hospital stay (median 23 days) and the highest percentage of invasive mechanical ventilation (81.02%) were observed during the 2nd and 3rd waves. Heart diseases and D-dimer were relevant during the Omicron stage. Clinical and demographic variables were similar between unvaccinated and vaccinated subjects, although the mortality was lower in the vaccinated group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These differences in the studied variables across pandemic waves and SARS-CoV-2 variants help explain the variability in clinical outcomes throughout the COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1794262","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:36:52Z","timestamp":1776922612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["An outlook on clinical and demographic variables in patients with severe COVID-19 across different waves in Mexico and SARS-CoV-2 variants: data from two high-specialty centers"],"prefix":"10.3389","volume":"14","author":[{"given":"Ingrid","family":"Fricke-Galindo","sequence":"first","affiliation":[{"name":"Pneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse Adriana","family":"Guti\u00e9rrez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Faculty of Chemical-Biological Sciences, Universidad Aut\u00f3noma de Guerrero, Chilpancingo","place":["Guerrero, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Lizbeth","family":"Ort\u00edz-Farias","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Enfermedades Respiratorias, Hospital Regional de alta Especialidad de la Pen\u00ednsula de Yucat\u00e1n\u2013IMSS Bienestar, M\u00e9rida","place":["Yucat\u00e1n, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Figueroa-Hurtado","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Enfermedades Respiratorias, Hospital Regional de alta Especialidad de la Pen\u00ednsula de Yucat\u00e1n\u2013IMSS Bienestar, M\u00e9rida","place":["Yucat\u00e1n, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris Paola","family":"Guzm\u00e1n-Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Faculty of Chemical-Biological Sciences, Universidad Aut\u00f3noma de Guerrero, Chilpancingo","place":["Guerrero, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"P\u00e9rez-Rubio","sequence":"additional","affiliation":[{"name":"Pneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivette","family":"Buend\u00eda-Rold\u00e1n","sequence":"additional","affiliation":[{"name":"Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Chavez-Galan","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Cort\u00e9s-Telles","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Enfermedades Respiratorias, Hospital Regional de alta Especialidad de la Pen\u00ednsula de Yucat\u00e1n\u2013IMSS Bienestar, M\u00e9rida","place":["Yucat\u00e1n, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramc\u00e9s","family":"Falf\u00e1n-Valencia","sequence":"additional","affiliation":[{"name":"Pneumogenomics Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cos\u00edo Villegas","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"955","DOI":"10.4269\/ajtmh.20-0849","article-title":"The origin of COVID-19 and why it matters","volume":"103","author":"Morens","year":"2020","journal-title":"Am J Trop Med Hyg."},{"key":"B2","unstructured":"COVID-19 cases | WHO COVID-19 dashboard"},{"key":"B3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/pathogens9030240","article-title":"Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2","volume":"9","author":"Rehman","year":"2020","journal-title":"Pathogens."},{"key":"B4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/cells10020206","article-title":"COVID-19: characteristics and therapeutics","volume":"10","author":"Chilamakuri","year":"2021","journal-title":"Cells."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3390\/biom10091312","article-title":"Why COVID-19 transmission is more efficient and aggressive than viral transmission in previous coronavirus epidemics?","volume":"10","author":"Elrashdy","year":"2020","journal-title":"Biomolecules."},{"key":"B6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s44298-025-00092-2","article-title":"Pathogenesis and transmission of SARS-CoV-2 D614G, alpha, gamma, delta, and omicron variants in golden hamsters","volume":"3","author":"Banete","year":"2025","journal-title":"NPJ Viruses."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.4103\/jfmpc.jfmpc_1884_23","article-title":"Comparative study between first three waves of COVID-19 pandemic with respect to risk factors, initial clinic-demographic profile, severity and outcome","volume":"13","author":"Thakur","year":"2024","journal-title":"J Family Med Prim Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.24875\/RMN.20000049","article-title":"The time of COVID-19: Clinical approaches and research within 2 months of arriving in Mexico","volume":"21","author":"V\u00e1zquez-Flores","year":"2020","journal-title":"Revista mexicana de neurociencia."},{"key":"B10","unstructured":"Informe integral de COVID-19 en M\u00e9xico\n          \n          \n            \n              Secretar\u00eda\n              de Salud S de PyP de la S\n            \n          \n          \n          2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/make7020055","article-title":"Factors associated with COVID-19 mortality in Mexico: a machine learning approach using clinical, socioeconomic, and environmental data","volume":"7","author":"D\u00edaz-Gonz\u00e1lez","year":"2025","journal-title":"Mach Learn Knowl Extract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e6150","DOI":"10.5281\/zenodo.12668018","article-title":"COVID-19 fatality rate conditioned by risk factors in Mexico in 2020","volume":"62","author":"Cordero-Franco","year":"2024","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43168-022-00122-0","article-title":"Predictors of severity and mortality in COVID-19 patients","volume":"16","author":"Assal","year":"2022","journal-title":"Egyptian J Bronchol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/jfmpc.jfmpc_941_21","article-title":"Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19","volume":"11","author":"Sana","year":"2022","journal-title":"J Family Med Prim Care."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1000147","DOI":"10.3389\/fmed.2022.1000147","article-title":"Outcome predictors in COVID-19: an analysis of emergent systemic inflammation indices in Mexican population","volume":"9","author":"Guti\u00e9rrez-P\u00e9rez","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1183\/2312508X.10018823","article-title":"Timeline of the pandemic: epidemiology, global spread, TS and waves","volume":"2024","author":"Liu","year":"2025","journal-title":"ERS Monograph"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e40113","DOI":"10.1016\/j.heliyon.2024.e40113","article-title":"Impact of SARS-CoV-2 variants on COVID-19 symptomatology and severity during five waves","volume":"10","author":"Gomes","year":"2024","journal-title":"Heliyon."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0264137","DOI":"10.1371\/journal.pone.0264137","article-title":"Association between living in municipalities with high crowding conditions and poverty and mortality from COVID-19 in Mexico","volume":"17","author":"Rios","year":"2022","journal-title":"PLoS ONE."},{"key":"B19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.24875\/NCT.M25000006","article-title":"A cinco a\u00f1os de la pandemia de COVID-19: nuevos retos de la medicina respiratoria y nuevas soluciones","volume":"84","author":"Salas-Hern\u00e1ndez","year":"2025","journal-title":"Neumolog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/ijerph21091243","article-title":"Evaluating access to health care in mothers and caregivers of children under five years of age in rural communities of Yucat\u00e1n, Mexico","volume":"21","author":"Rodr\u00edguez","year":"2024","journal-title":"Int J Environ Res Public Health."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B22","unstructured":"Vigilancia\n              de variantes del virus SARS-CoV-2"},{"key":"B23","unstructured":""},{"key":"B24","unstructured":"RStudio: Integrated Development Environment for R.\n          \n          2025"},{"key":"B25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21149\/14877","article-title":"The impact of the Covid-19 vaccination policy in Mexico. A quasi-experimental effectiveness evaluation of a multi-vaccine strategy","volume":"66","author":"Bautista-Arredondo","year":"2024","journal-title":"Salud Publica Mex."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/soej.12488","article-title":"The political economy of the COVID-19 pandemic","volume":"87","author":"Boettke","year":"2021","journal-title":"South Econ J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1093\/cid\/ciab721","article-title":"et al. Clinical and virological features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective cohort study comparing B117 (alpha), B1351 (beta), and B16172 (delta)","volume":"75","author":"Ong","year":"2022","journal-title":"Clin Infect Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13690-024-01432-z","article-title":"Mortality from type 2 diabetes mellitus across municipalities in Mexico","volume":"82","author":"Cervantes","year":"2024","journal-title":"Archives Public Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3855\/jidc.17428","article-title":"Prognostic factors of COVID-19 severity and mortality in the Yucatecan ethnic of M\u00e9xico contrast with other populations","volume":"17","author":"S\u00e1nchez-Burgos","year":"2023","journal-title":"J Infect Dev Ctries."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.18632\/aging.103344","article-title":"Why does COVID-19 disproportionately affect older people?","volume":"12","author":"Mueller","year":"2020","journal-title":"Aging (Albany NY)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"100259","DOI":"10.1016\/j.ahr.2025.100259","article-title":"Exploring age-related influences on COVID-19 severity and therapeutic approaches for older patients","volume":"5","author":"Hossain","year":"2025","journal-title":"Aging Health Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1017\/S0950268820003027","article-title":"A meta-analysis of the association between obesity and COVID-19","volume":"149","author":"Yang","year":"2020","journal-title":"Epidemiol Infect."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e11711","DOI":"10.1590\/1414-431x2021e11711","article-title":"Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age Brazilian","volume":"55","author":"Fabi\u00e3o","year":"2022","journal-title":"J Med Biol Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.47102\/annals-acadmedsg.202535","article-title":"Omicron SARS-CoV-2 outcomes in vaccinated individuals with heart failure and ischaemic heart disease","volume":"54","author":"Wee","year":"2025","journal-title":"Ann Acad Med Singap."},{"key":"B35","doi-asserted-by":"publisher","first-page":"107958","DOI":"10.1016\/j.ijid.2025.107958","article-title":"Risk of severe outcomes from COVID-19 in comorbid populations in the Omicron era: a systematic review and meta-analysis","volume":"158","author":"Chapman","year":"2025","journal-title":"Int J Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1383252","DOI":"10.3389\/fmed.2024.1383252","article-title":"Clinical characteristics and risk factors in patients with SARS-CoV-2 Omicron variant infection complicated with cardiovascular diseases","volume":"11","author":"Yu","year":"2024","journal-title":"Front Med (Lausanne)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1177\/00031348221091940","article-title":"Correlation of D-dimer and outcomes in COVID-19 patients","volume":"88","author":"Nemec","year":"2022","journal-title":"Am Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ajh.25482","article-title":"The D-dimer assay","volume":"94","author":"Johnson","year":"2019","journal-title":"Am J Hematol."},{"key":"B39","first-page":"e2020008","article-title":"Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis","volume":"91","author":"Henry","year":"2020","journal-title":"Acta Bio Medica : Atenei Parmensis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/B0-72-168903-5\/50008-2","article-title":"Leukocyte disorders","author":"Raskin","year":"2009","journal-title":"Small Animal Clin Diagnosis Lab Methods"},{"key":"B41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12964-024-01718-3","article-title":"SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147","volume":"22","author":"Shouman","year":"2024","journal-title":"Cell Communication Signaling."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e017756","DOI":"10.1161\/JAHA.120.017756","article-title":"Coronavirus 2019 disease (COVID-19), systemic inflammation, and cardiovascular disease","volume":"9","author":"Inciardi","year":"2020","journal-title":"J Am Heart Assoc: Cardiovascul Cerebrovascul Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e13097","DOI":"10.1111\/sji.13097","article-title":"Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: a systematic review","volume":"94","author":"Tomerak","year":"2021","journal-title":"Scand J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","article-title":"Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa","volume":"116","author":"Abdullah","year":"2022","journal-title":"Int J Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jama.2021.24868","article-title":"Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous Waves","volume":"327","author":"Maslo","year":"2021","journal-title":"JAMA."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.15585\/mmwr.mm7137a4","article-title":"Mortality risk among patients hospitalized primarily for COVID-19 during the omicron and delta variant pandemic periods\u2013United States, April 2020\u2013June 2022","volume":"71","author":"Adjei","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41479-025-00158-y","article-title":"Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza","volume":"17","author":"Hozumi","year":"2025","journal-title":"Pneumonia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-024-09139-w","article-title":"Impact of vaccination status on clinical outcomes of hospitalized COVID-19 patients","volume":"24","author":"Gholinataj Jelodar","year":"2024","journal-title":"BMC Infect Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/22221751.2022.2069516","article-title":"Impact of prior vaccination on clinical outcomes of patients with COVID-19","volume":"11","author":"Seo","year":"2022","journal-title":"Emerg Microbes Infect."},{"key":"B50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/tropicalmed6040175","article-title":"Clinical Outcomes of Adult Patients Hospitalized with COVID-19 after Vaccination","volume":"6","author":"Kalligeros","year":"2021","journal-title":"Tropic Med Infect Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e28781","DOI":"10.1016\/j.heliyon.2024.e28781","article-title":"Effect of vaccination on COVID-19 mortality during omicron wave among highly marginalized Mexican population","volume":"10","author":"\u00c1lvarez-S\u00e1nchez","year":"2024","journal-title":"Heliyon."},{"key":"B52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/S43856-023-00277-X","article-title":"Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity","volume":"3","author":"Dietz","year":"2023","journal-title":"Commun Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"817597","DOI":"10.3389\/fimmu.2022.817597","article-title":"The effect of age gender gender and comorbidities upon SARS-CoV-2 spike antibody induction after two doses of sinopharm vaccine and the effect of a pfizer\/biontech booster vaccine","volume":"13","author":"Farid","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1794262\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:36:55Z","timestamp":1776922615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1794262\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":53,"alternative-id":["10.3389\/fpubh.2026.1794262"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1794262","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"article-number":"1794262"}}